Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-14-004493
Filing Date
2014-06-25
Accepted
2014-06-25 16:07:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b5062514_actiniumpharma.htm 424B5 935351
2 logo.jpg GRAPHIC 42060
3 img1.jpg GRAPHIC 33830
  Complete submission text file 0001213900-14-004493.txt   1041173
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-194768 | Film No.: 14940094
SIC: 6770 Blank Checks